For the 15th Annual event, the flagship OCT show will focus on providing delegates with practical take-aways and solutions to their most current operational and […]
How can you access larger pools of clinical trial participants? Gain the ability to target specific populations? Address potential ethical considerations? Ensure timely data accuracy? […]
Webinar - The Future of Data Platforms For Digital Biomarkers: Accelerating Parkinson’s Disease and Movement Disorders Research Parkinson's Disease and Movement Disorder research is accelerating […]
11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central) Systemic Lupus Erythematosus (SLE) clinical trials are complex and can be challenging to conduct. […]
For years, diabetes clinical trials have been trailing clinical care because of regulatory and logistical challenges with utilizing CGMs in a clinical trial setting. But, because of recent FDA clearance of commercially available devices, these CGM devices have started to be implemented more widely in the clinical trial setting – at least in the United States – but global trials still present challenges.
Don't miss Clinical ink Principal Scientist David Anderson on "Predicting ALS Progression in Remote Sensor-Based Assessments" at the International Congress of Parkinson’s Disease and Movement […]
In this informative webinar, discover strategies for patient engagement and digital therapeutics relating to the management of social determinants of health in cardiometabolic diseases and recent Food and Drug Administration (FDA) guidance on the future of Lupus research.
Come hear David Anderson, PhD speak at SCOPE on Tuesday February 13th at 5:30pm. David will be presenting Clinical ink’s latest offering, GlucoseReady™: A Digital […]
We are excited to announce that David Anderson will be presenting at #DIAEurope March 12-14, 2024 on “A feasibility study of smartphone sensors to assess the effect of acute high altitude […]
In this informative webinar, discover strategies for patient engagement and digital therapeutics relating to the management of social determinants of health in cardiometabolic diseases and recent Food and Drug Administration (FDA) guidance on the future of Lupus research.
Will you be attending SCOPE 2025? Don't miss our session, Unifying Multi-Vendor Wearables/Sensors Data Collection for Clinical Trial Regulatory Compliance on Thursday, February 6, 2025 […]
Join us at the 17th Annual Outsourcing in Clinical Trials West Coast 2025 conference in San Francisco on February 11-12, 2025. We’re thrilled to be […]
Sales and Solutions
Direct 1.336.464.0697
Support
Toll-Free 1.800.301.5033
Direct 1.336.464.0697
Insert HTML text here.
Request more information, submit questions, set up a demonstration, and more.
